These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23016716)

  • 1. Targeting myocardial metabolism for the treatment of stable angina.
    Tousoulis D; Bakogiannis C; Briasoulis A; Papageorgiou N; Androulakis E; Siasos G; Latsios G; Kampoli AM; Charakida M; Toutouzas K; Stefanadis C
    Curr Pharm Des; 2013; 19(9):1587-92. PubMed ID: 23016716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial fatty acid oxidation inhibitors for stable angina.
    Stanley WC
    Expert Opin Investig Drugs; 2002 May; 11(5):615-29. PubMed ID: 11996644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change of myocardial glucose and free fatty acid metabolism and effect of electroacupuncture on them during experimental myocardial angina].
    Gao C; Meng J; Fu W; Song L
    Zhen Ci Yan Jiu; 1990; 15(1):66-70. PubMed ID: 2118010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update.
    Guarini G; Huqi A; Morrone D; Marzilli M
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):379-391. PubMed ID: 27497930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic energy metabolism in diabetes: therapeutic implications.
    Pogatsa G
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S29-33. PubMed ID: 11286305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolical effects of L-carnitine in angina pectoris.
    Ferrari R; Cucchini F; Visioli O
    Int J Cardiol; 1984 Feb; 5(2):213-6. PubMed ID: 6698646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs that Affect Cardiac Metabolism: Focus on Perhexiline.
    Chong CR; Sallustio B; Horowitz JD
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):399-405. PubMed ID: 27106834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial release of inosine, hypoxanthine and lactate during pacing-induced angina in humans with coronary artery disease.
    Kugler G
    Eur J Cardiol; 1979 Mar; 9(3):227-40. PubMed ID: 421723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up.
    Mathiasen AB; Haack-Sørensen M; Jørgensen E; Kastrup J
    Int J Cardiol; 2013 Dec; 170(2):246-51. PubMed ID: 24211066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Persistent" angina: rationale for a metabolic approach].
    Marzilli M
    Ital Heart J; 2004 Mar; 5 Suppl 2():37S-41S. PubMed ID: 15074776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of electroacupuncture on myocardial oxygen metabolism and pH of coronary sinus blood during experimental angina pectoris].
    Gao C; Meng J; Fu W; Song L
    Zhen Ci Yan Jiu; 1992; 17(1):28-32. PubMed ID: 1394952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.
    Watanabe K; Takahashi T; Miyajima S; Hirokawa Y; Tanabe N; Kato K; Kodama M; Aizawa Y; Tazawa S; Inoue M
    J Nucl Med; 2002 Nov; 43(11):1476-81. PubMed ID: 12411551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies.
    Stanley WC
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S31-45. PubMed ID: 15378130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.
    Wolff AA; Rotmensch HH; Stanley WC; Ferrari R
    Heart Fail Rev; 2002 Apr; 7(2):187-203. PubMed ID: 11988642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angina pectoris with normal coronary arteries: clinical, hemodynamic and metabolic study].
    Letac B; Berland J; Cribier A; Cazor JL; Hecketsweiler B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():211-22. PubMed ID: 6407443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
    Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
    Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease.
    Beadle RM; Frenneaux M
    Heart; 2010 Jun; 96(11):824-30. PubMed ID: 20478861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-anginal effects of partial fatty acid oxidation inhibitors.
    Lam A; Lopaschuk GD
    Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.